Essential Properties Realty Trust, Inc. filed a Form 8-K with the SEC on September 14, 2026, disclosing the release of an investor presentation intended for use in meetings with investors.
Definium Therapeutics, Inc. filed a Form 8-K with the SEC on September 14, 2026, disclosing positive topline data from its Phase 3 Panorama study of DT120 ODT for the treatment of generalized anxiety disorder, along with an accompanying investor presentation posted to the company's …
Eos Energy Enterprises, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on September 14, 2026, disclosing that the Federal Financing Bank funded a third advance of $87,018,601 under its DOE-guaranteed promissory note on September 10, 2026.
Graco Inc. filed a Form 8-K on September 14, 2026, disclosing that its Board of Directors appointed Richard B. Lewis as a new director, effective December 3, 2026, with an assignment to the Audit Committee.
Rimini Street, Inc. filed a Form 8-K on September 14, 2026, disclosing the reinstatement of Steven Hershkowitz as Executive Vice President and Chief Revenue Officer, effective the same date, following his previously reported resignation on September 8, 2026.
Bowman Consulting Group Ltd. filed a current report on Form 8-K on September 14, 2026, disclosing that the "go-shop" period established under its previously announced Agreement and Plan of Merger with Prive Parent, Inc. and Prive Merger Sub, Inc. has expired.
Summit Therapeutics Inc. filed a Form 8-K on September 14, 2026, disclosing that its partner Akeso Inc. announced the presentation of updated data, including overall survival, from the Phase III HARMONi-2 trial at the International Association for the Study of Lung Cancer's 2026 World …
Hyperliquid Strategies Inc filed a Form 8-K on September 14, 2026, disclosing that it entered into Amendment No. 2 to its ChEF Purchase Agreement with Chardan Capital Markets LLC, revising the per-share purchase price terms for common stock sales under the agreement.
A10 Networks, Inc. filed a Form 8-K with the SEC on September 14, 2026, disclosing the appointment of Mary C. Henry as a new member of its Board of Directors, effective October 5, 2026.
TransDigm Group Incorporated filed a Form 8-K with the SEC on September 14, 2026, disclosing that its wholly-owned subsidiary TransDigm Inc. has commenced a cash tender offer for any and all of its outstanding 6.75% Senior Secured Notes due 2028.